Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Condition: Renal Cell Carcinoma Interventions: Drug: Neoadjuvant Lenvatinib; Drug: Neoadjuvant Pembrolizumab; Procedure: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection; Drug: Adjuvant Pembrolizumab Sponsor: University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Neoadjuvant Therapy | Nephrectomy | Research | Thrombosis